Monthly Archives: February 2011

Judging a Drug by its Cover: How Packaging Promotes Patient Adherence

By Jennifer Ringler | Published: February 7, 2011
Patient adherence is a chronic issue in healthcare, leading to poor disease management, higher hospitalization rates, and lost revenue for Big Pharma. But one often overlooked facet of the complicated chain of events from R&D to marketing to prescribing may hold the key. Patient adherence is not a new issue in the industry; still, the [...]
Posted in Strategy | Tagged , , , | 3 Comments

Pfizer Site Closure "Shocking Wake-Up Call" for UK

By Julian Upton | Published: February 2, 2011
It’s not too often that a pharma facility closure tops the TV news headlines but that was the case in the UK yesterday following Pfizer’s announcement that it is to close the UK-based R&D centre that achieved worldwide fame as “the home of Viagra”.
Posted in Europe, Strategy | Tagged , , , , , | Leave a comment

In the Absence of Avastin: New Opportunity

By Jennifer Ringler | Published: February 2, 2011
written by guest blogger Ed Kissel, Vice President of Quantitative Analysis In July 2010, an advisory panel voted 12-1 to urge the FDA to withdraw the approved use of Avastin in metastatic HER2-negative breast cancer. As a result of this announcement, IntrinsiQ hypothesized that physicians would immediately decrease the use the drug in new [...]
Posted in Strategy | Tagged , | Leave a comment

California Biotech — Good Governance Tops Wish List

By William Looney | Published: February 2, 2011
New industry survey data documents a fraying investment base marked by a distant and unresponsive FDA as well as an unprepared work force complacent about hungry foreign competition. California’s biotech industry has taken its annual pulse of business conditions — and while the prognosis is not for putting the state on the policy equivalent of life [...]
Posted in Biotech, FDA, R&D, Strategy, healthcare | Tagged , , , , , | Leave a comment

Freda Lewis-Hall Named HBA Woman of the Year 2011

By Jennifer Ringler | Published: February 1, 2011
Freda Lewis-Hall, MD, chief medical officer of Pfizer has been named 2011 Woman of the Year (WOTY) by the Healthcare Businesswomen’s Association (HBA). In her 30-year career, Dr. Lewis-Hall has held leadership roles in direct patient care, academics, media, government, pharmaceuticals, and biotechnology. Among her most recent achievements, in September 2010, Dr. Lewis-Hall was appointed by [...]
Posted in Strategy | Tagged , , | Leave a comment